Compile Data Set for Download or QSAR
Report error Found 1751 of affinity data for UniProtKB/TrEMBL: Q9UGN5
TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM167408(US9073893, 1)
Affinity DataKd:  780nMAssay Description:Affinity evaluation of the tested compounds and their selectivity with respect to the different PARP isoforms of interest was assessed in a displacem...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/29/2016
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM167409(US9073893, 2)
Affinity DataKd:  1.49E+3nMAssay Description:Affinity evaluation of the tested compounds and their selectivity with respect to the different PARP isoforms of interest was assessed in a displacem...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/29/2016
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM167412(US9073893, 5)
Affinity DataKd:  540nMAssay Description:Affinity evaluation of the tested compounds and their selectivity with respect to the different PARP isoforms of interest was assessed in a displacem...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/29/2016
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM167413(US9073893, 6)
Affinity DataKd:  1.88E+3nMAssay Description:Affinity evaluation of the tested compounds and their selectivity with respect to the different PARP isoforms of interest was assessed in a displacem...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/29/2016
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM167414(US9073893, 7)
Affinity DataKd:  50nMAssay Description:Affinity evaluation of the tested compounds and their selectivity with respect to the different PARP isoforms of interest was assessed in a displacem...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/29/2016
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM167415(US9073893, 8)
Affinity DataKd:  40nMAssay Description:Affinity evaluation of the tested compounds and their selectivity with respect to the different PARP isoforms of interest was assessed in a displacem...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/29/2016
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM167416(US9073893, 9)
Affinity DataKd:  140nMAssay Description:Affinity evaluation of the tested compounds and their selectivity with respect to the different PARP isoforms of interest was assessed in a displacem...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/29/2016
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM167417(US9073893, 14)
Affinity DataKd:  30nMAssay Description:Affinity evaluation of the tested compounds and their selectivity with respect to the different PARP isoforms of interest was assessed in a displacem...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/29/2016
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM167420(US9073893, 20)
Affinity DataKd:  300nMAssay Description:Affinity evaluation of the tested compounds and their selectivity with respect to the different PARP isoforms of interest was assessed in a displacem...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/29/2016
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM167421(US9073893, 21)
Affinity DataKd:  70nMAssay Description:Affinity evaluation of the tested compounds and their selectivity with respect to the different PARP isoforms of interest was assessed in a displacem...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/29/2016
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM167422(US9073893, 22)
Affinity DataKd:  500nMAssay Description:Affinity evaluation of the tested compounds and their selectivity with respect to the different PARP isoforms of interest was assessed in a displacem...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/29/2016
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM167423(US9073893, 23)
Affinity DataKd:  5.00E+3nMAssay Description:Affinity evaluation of the tested compounds and their selectivity with respect to the different PARP isoforms of interest was assessed in a displacem...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/29/2016
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM240704(US9422243, 1)
Affinity DataKd:  1.03E+3nMAssay Description:The identification of compounds capable of binding several PARP proteins is carried out through a screening method including the steps of a) provi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2017
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM240705(US9422243, 2)
Affinity DataKd:  1.96E+3nMAssay Description:The identification of compounds capable of binding several PARP proteins is carried out through a screening method including the steps of a) provi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2017
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM240706(US9422243, 3)
Affinity DataKd:  7.20E+3nMAssay Description:The identification of compounds capable of binding several PARP proteins is carried out through a screening method including the steps of a) provi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2017
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM240707(US9422243, 4)
Affinity DataKd:  240nMAssay Description:The identification of compounds capable of binding several PARP proteins is carried out through a screening method including the steps of a) provi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2017
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM240708(US9422243, 5)
Affinity DataKd:  1.00E+3nMAssay Description:The identification of compounds capable of binding several PARP proteins is carried out through a screening method including the steps of a) provi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2017
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM240709(US9422243, 6)
Affinity DataKd:  540nMAssay Description:The identification of compounds capable of binding several PARP proteins is carried out through a screening method including the steps of a) provi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2017
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM240710(US9422243, 7)
Affinity DataKd:  1.19E+3nMAssay Description:The identification of compounds capable of binding several PARP proteins is carried out through a screening method including the steps of a) provi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2017
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM50110826(CHEMBL3605972 | US10800739, Compound (2) | US11420...)
Affinity DataKd:  180nMAssay Description:Preferably, for the screening method above cited, both the PARP protein and the 5H-phenanthridin-6-one-derived probe of formula (IP) are pre-mixed, o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM50110833(CHEMBL3605983 | US10800739, Compound (3) | US11420...)
Affinity DataKd:  5.80E+3nMAssay Description:Preferably, for the screening method above cited, both the PARP protein and the 5H-phenanthridin-6-one-derived probe of formula (IP) are pre-mixed, o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM50110829(CHEMBL3605976 | US10800739, Compound (15) | US1142...)
Affinity DataKd:  5.87E+3nMAssay Description:Preferably, for the screening method above cited, both the PARP protein and the 5H-phenanthridin-6-one-derived probe of formula (IP) are pre-mixed, o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM50110832(CHEMBL3605982 | US10800739, Compound (16))
Affinity DataKd:  420nMAssay Description:Preferably, for the screening method above cited, both the PARP protein and the 5H-phenanthridin-6-one-derived probe of formula (IP) are pre-mixed, o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM50110810(CHEMBL3606009 | US10800739, Compound (9) | US11420...)
Affinity DataKd:  1.44E+3nMAssay Description:Preferably, for the screening method above cited, both the PARP protein and the 5H-phenanthridin-6-one-derived probe of formula (IP) are pre-mixed, o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM50110808(CHEMBL3606007 | US10800739, Compound (10) | US1142...)
Affinity DataKd:  6.80E+3nMAssay Description:Preferably, for the screening method above cited, both the PARP protein and the 5H-phenanthridin-6-one-derived probe of formula (IP) are pre-mixed, o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM466534(US10800739, Compound (11) | US11420940, cpd (11))
Affinity DataKd:  1.40E+3nMAssay Description:Preferably, for the screening method above cited, both the PARP protein and the 5H-phenanthridin-6-one-derived probe of formula (IP) are pre-mixed, o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM50110812(CHEMBL3606011 | US10800739, Compound (12) | US1142...)
Affinity DataKd:  1.70E+3nMAssay Description:Preferably, for the screening method above cited, both the PARP protein and the 5H-phenanthridin-6-one-derived probe of formula (IP) are pre-mixed, o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM50113458(CHEMBL3605975 | US10800739, Compound (14))
Affinity DataKd:  580nMAssay Description:Preferably, for the screening method above cited, both the PARP protein and the 5H-phenanthridin-6-one-derived probe of formula (IP) are pre-mixed, o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM50110832(CHEMBL3605982 | US10800739, Compound (16))
Affinity DataKd:  980nMAssay Description:Preferably, for the screening method above cited, both the PARP protein and the 5H-phenanthridin-6-one-derived probe of formula (IP) are pre-mixed, o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM50110827(CHEMBL3605973 | US10800739, Compound (17) | US1142...)
Affinity DataKd:  290nMAssay Description:Preferably, for the screening method above cited, both the PARP protein and the 5H-phenanthridin-6-one-derived probe of formula (IP) are pre-mixed, o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM466541(US10800739, Compound (19) | US11420940, cpd (19))
Affinity DataKd:  1.39E+3nMAssay Description:Preferably, for the screening method above cited, both the PARP protein and the 5H-phenanthridin-6-one-derived probe of formula (IP) are pre-mixed, o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM466542(US10800739, Compound (20) | US11420940, cpd (20))
Affinity DataKd:  190nMAssay Description:Preferably, for the screening method above cited, both the PARP protein and the 5H-phenanthridin-6-one-derived probe of formula (IP) are pre-mixed, o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM50110840(CHEMBL3605994 | US10800739, Compound (24) | US1142...)
Affinity DataKd:  4.40E+4nMAssay Description:Preferably, for the screening method above cited, both the PARP protein and the 5H-phenanthridin-6-one-derived probe of formula (IP) are pre-mixed, o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM50110831(CHEMBL3605981 | US10800739, Compound (32) | US1142...)
Affinity DataKd:  660nMAssay Description:Preferably, for the screening method above cited, both the PARP protein and the 5H-phenanthridin-6-one-derived probe of formula (IP) are pre-mixed, o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM50110826(CHEMBL3605972 | US10800739, Compound (2) | US11420...)
Affinity DataKd:  180nMAssay Description:The assay is based on the use of a probe of formula (IP) that binds to the NAD binding pocket and takes advantage of the significant change in the po...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM50110833(CHEMBL3605983 | US10800739, Compound (3) | US11420...)
Affinity DataKd:  5.80E+3nMAssay Description:The assay is based on the use of a probe of formula (IP) that binds to the NAD binding pocket and takes advantage of the significant change in the po...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM50110829(CHEMBL3605976 | US10800739, Compound (15) | US1142...)
Affinity DataKd:  5.87E+3nMAssay Description:The assay is based on the use of a probe of formula (IP) that binds to the NAD binding pocket and takes advantage of the significant change in the po...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM566634(US11420940, cpd (7))
Affinity DataKd:  420nMAssay Description:The assay is based on the use of a probe of formula (IP) that binds to the NAD binding pocket and takes advantage of the significant change in the po...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM50110810(CHEMBL3606009 | US10800739, Compound (9) | US11420...)
Affinity DataKd:  1.44E+3nMAssay Description:The assay is based on the use of a probe of formula (IP) that binds to the NAD binding pocket and takes advantage of the significant change in the po...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM50110808(CHEMBL3606007 | US10800739, Compound (10) | US1142...)
Affinity DataKd:  6.80E+4nMAssay Description:The assay is based on the use of a probe of formula (IP) that binds to the NAD binding pocket and takes advantage of the significant change in the po...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM466534(US10800739, Compound (11) | US11420940, cpd (11))
Affinity DataKd:  1.40E+3nMAssay Description:The assay is based on the use of a probe of formula (IP) that binds to the NAD binding pocket and takes advantage of the significant change in the po...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM50110812(CHEMBL3606011 | US10800739, Compound (12) | US1142...)
Affinity DataKd:  1.70E+3nMAssay Description:The assay is based on the use of a probe of formula (IP) that binds to the NAD binding pocket and takes advantage of the significant change in the po...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM50110813(CHEMBL3606012 | US11420940, cpd (14))
Affinity DataKd:  580nMAssay Description:The assay is based on the use of a probe of formula (IP) that binds to the NAD binding pocket and takes advantage of the significant change in the po...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM50113460(CHEMBL3606013 | US11420940, cpd (16))
Affinity DataKd:  980nMAssay Description:The assay is based on the use of a probe of formula (IP) that binds to the NAD binding pocket and takes advantage of the significant change in the po...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM50110827(CHEMBL3605973 | US10800739, Compound (17) | US1142...)
Affinity DataKd:  290nMAssay Description:The assay is based on the use of a probe of formula (IP) that binds to the NAD binding pocket and takes advantage of the significant change in the po...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM466541(US10800739, Compound (19) | US11420940, cpd (19))
Affinity DataKd:  1.39E+3nMAssay Description:The assay is based on the use of a probe of formula (IP) that binds to the NAD binding pocket and takes advantage of the significant change in the po...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM466542(US10800739, Compound (20) | US11420940, cpd (20))
Affinity DataKd:  190nMAssay Description:The assay is based on the use of a probe of formula (IP) that binds to the NAD binding pocket and takes advantage of the significant change in the po...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM50110840(CHEMBL3605994 | US10800739, Compound (24) | US1142...)
Affinity DataKd:  4.40E+4nMAssay Description:The assay is based on the use of a probe of formula (IP) that binds to the NAD binding pocket and takes advantage of the significant change in the po...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM50110831(CHEMBL3605981 | US10800739, Compound (32) | US1142...)
Affinity DataKd:  660nMAssay Description:The assay is based on the use of a probe of formula (IP) that binds to the NAD binding pocket and takes advantage of the significant change in the po...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Nerviano Medical Sciences

US Patent
LigandPNGBDBM124951(US8765972, 4)
Affinity DataKd: >1.00E+4nMAssay Description:Displacement of fluorescent probe from human recombinant full length His-tagged PARP2 by fluorescent polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed
Displayed 1 to 50 (of 1751 total ) | Next | Last >>
Jump to: